智通财经APP讯，昭衍新药(06127)发布公告，2025年1月，公司通过集中竞价交易方式回购A股股份61.37万股，占公司本公告日总股份的0.0819%，回购最高价格为人民币17.20元/股，回购最低价格为人民币16.35元/股，使用资金总额为人民币1033.35万元(不含交易费用)。
截至2025年1月31日，公司累计通过集中竞价交易方式回购A股股份326.98万股，占公司本公告日总股份的0.4363%，回购最高价格为人民币18.15元/股，回购最低价格为人民币13.20元/股，使用资金总额为人民币5299.18万元(不含交易费用)。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.